A comprehensive view of Illnesses / Symptoms / Conditions. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Pulp & Paper Industry Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Patent Issued for Protein solution formulation containing high concentration of an anti-VEGF antibody (USPTO 11945859)
Published: April 19, 2024 by Angiogenesis Daily
Phase 3 study of Roche's OCREVUS subcutaneous injection shows near-complete suppression of multiple sclerosis relapse activity and lesions; approval anticipated from FDA and EMA in 2024
Published: April 17, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Sanofi's frexalimab shows high efficacy in 48-week Phase 2 trial for multiple sclerosis, with an annualized relapse rate of 0.04 for high-dose variants; Phase 3 studies have begun for both relapsing and non-relapsing secondary progressive MS
Published: April 17, 2024 by Sanofi SA
Kao Corp and Epsilon Molecular Eng File United States Patent Application for Anti-SARS-CoV-2 Antibody
Published: April 16, 2024 by Pharmaceutical Patent News
AstraZeneca's IMPACT CKD model predicts chronic kidney disease could impact up to 16.5% of population across US, Brazil, UK, Spain, Germany, Netherlands, China, and Australia by 2032; advanced stages could increase by 59.3%
Published: April 15, 2024 by AstraZeneca AB

Ask us about our Pulp & Paper Industry market view

Trending Chart

Interactive chart with headline count